BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

National Cancer Coalition (NCC) Donates Cancer Medicines To Paraguay


10/19/2005 5:11:08 PM

NEW ORLEANS, April 21 /PRNewswire/ -- The National Cancer Coalition (NCC) http://www.nationalcancercoalition.org/ announces the donation of $3 million worth of cancer medicines and essential pharmaceuticals to assist the needy in Paraguay.

A hand-over ceremony was held in Asuncion to recognize NCC's donation of medical goods. Paraguayan Health Minister Julio Valezquez, NCC President Robert Landry, and USAID Paraguay Director Wayne Nilsestuen participated in the hand-over ceremony, which was extensively covered by the Paraguayan media. A delegation also toured the children's pediatric cancer hospital that received some of the donated medicines.

Robert B. Landry, III, President & CEO of National Cancer Coalition stated, "We are pleased to assist Paraguay as it improves cancer treatment provided to its citizens. NCC has made a number of significant donations to the public hospitals of Paraguay that serve needy cancer patients."

Landry added that creating awareness for individuals to seek care and early detection of cancer is important in a country like Paraguay. NCC is working closely with local public hospitals and the Paraguayan media to alert the public that specific cancer medicines are now available free of charge for needy individuals with cancer.

"With almost 60 percent of its population living at or under the poverty line, Paraguay is in great need of humanitarian assistance. Our donations include medications for treatment of breast cancer and various types of solid tumors. In addition, we provide essential antibiotics for treatment of these patients that are quite susceptible to infections, because of their weakened immune systems."

Since initiating its program in Paraguay, NCC has provided over $3 million in cancer medicines and essential pharmaceuticals to the country's public cancer hospitals. Landry stated that NCC opened an office in the capital city of Asuncion in October 2004 to support its expanding program within Paraguay.

NCC, a 501(c)(3) not-for-profit corporation headquartered in New Orleans, LA, supports cancer research and undertakes educational, prevention and medical relief programs throughout the world. Through its Angel Grants program, NCC supports cutting-edge cancer research in the United States.

NCC's international medical assistance program, termed "NCC Cares," provides requested pharmaceuticals, medical equipment, and hospital supplies to public hospitals and local humanitarian organizations that help the needy in over 20 developing countries around the world. The Coalition also distributes educational materials and sponsors community health screenings.

For additional information, please contact National Cancer Coalition at: 504-301-1461 or visit: http://www.nationalcancercoalition.org/

National Cancer Coalition

CONTACT: National Cancer Coalition, +1-504-301-1461



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES